Corrected QT interval in electrocardiogram recordings in patients treated with calcium channel blockers

Introduction One of the most popular tests of the heart is the electrocardiogram (ECG). The physical basis of this study has been known for over 200 years. However, the way an ECG is performed and the interpretation of the obtained results have undergone considerable evolution over time. Aim To analyze the ECG recordings regarding the QTc interval in patients taking calcium channel blockers. Material and methods The publicly available PhysioNet signals database was used to analyze the effect of selected drugs on the heart rhythm and QTc interval. To automate the QTc assessment, the database was processed in MATLAB. First, QTc was assessed using four formulas; then the results were compared in terms of methodology and medications taken. Results In the group of patients taking dihydropyridine blockers, the QTc interval assessed by the Bazett formula (mean: 478.87 ms; SD: 73.10) is longer than in patients taking non-dihydropyridine blockers (mean: 446.54 ms, SD: 88.07, p = 0.2123) and in patients not taking calcium channel blockers (mean: 436.33 ms, SD: 49.94, p = 0.0319). The same significant differences were obtained regardless of the QTc assessment method used. However, the QTc result obtained with the Bazett formula is significantly lower than in the case of using the other three formulas used for the presented analysis. Conclusions Automatic ECG analysis is possible; however, it should be used carefully, considering the possibility of obtaining incorrect results. Taking calcium channel blockers may affect the QTc interval. QTc results significantly depend on the formula based on which we evaluate this parameter.

[1]  A. Raviele,et al.  Clinical Approach to Patients with Palpitations. , 2018, Cardiac electrophysiology clinics.

[2]  J. Ector,et al.  Which QT Correction Formulae to Use for QT Monitoring? , 2016, Journal of the American Heart Association.

[3]  R. Fogari,et al.  Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus , 2012, Diabetes, obesity & metabolism.

[4]  M. Nieminen,et al.  Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men , 2009, Annals of medicine.

[5]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[6]  J. Klimas,et al.  Prolonged QT Interval Is Associated with Blood Pressure Rather Than Left Ventricular Mass in Spontaneously Hypertensive Rats , 2008, Clinical and experimental hypertension.

[7]  A. Moss,et al.  QT Interval: How to Measure It and What Is “Normal” , 2006, Journal of cardiovascular electrophysiology.

[8]  Peter W Macfarlane,et al.  A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. , 2004, Journal of electrocardiology.

[9]  A. Waller A Demonstration of Man of Electromotive Changes Accompanying the Heart's Beat , 2004, The Journal of physiology.

[10]  L. S. Fridericia,et al.  The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease * , 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[11]  L. Fauchier,et al.  Effect of verapamil on QT interval dynamicity. , 1999, The American journal of cardiology.

[12]  T. MacDonald,et al.  Irbesartan reduces QT dispersion in hypertensive individuals. , 1999, Hypertension.

[13]  Morrison Hodges,et al.  Rate Correction of the QT Interval , 1997 .

[14]  P Jaillon,et al.  Rate-corrected QT interval: techniques and limitations. , 1993, The American journal of cardiology.

[15]  D. Levy,et al.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) , 1992, The American journal of cardiology.

[16]  G. Moody,et al.  The European ST-T database: standard for evaluating systems for the analysis of ST-T changes in ambulatory electrocardiography. , 1992, European heart journal.

[17]  D. Haines,et al.  Current therapy for supraventricular tachycardia. , 1992, Current problems in cardiology.

[18]  C. Funck-Brentano,et al.  Effects of bepridil and diltiazem on ventricular repolarization in angina pectoris. , 1990, The American journal of cardiology.

[19]  I. V. Van Gelder,et al.  Electrophysiological Properties of Isradipine (PN200–110) in Humans , 1989, Journal of cardiovascular pharmacology.

[20]  K. Nademanee,et al.  Calcium Antagonists , 2012, Drugs.

[21]  Shirley A. Jones ECG Notes Interpretation and Management Guide , 2009 .

[22]  M. Eisenberg,et al.  Calcium channel blockers: an update. , 2004, The American journal of medicine.

[23]  Jeffrey M. Hausdorff,et al.  Physionet: Components of a New Research Resource for Complex Physiologic Signals". Circu-lation Vol , 2000 .

[24]  L. Lind,et al.  Electrocardiographic changes during antihypertensive treatment with diltiazem in relation to the achieved serum levels of the drug. , 1994, Scandinavian journal of clinical and laboratory investigation.